Join to View Full Profile
Lilly Corporate CenterIndianapolis, IN 46278Indianapolis, IN 46285
Phone+1 317-433-3737
Dr. Melemed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Indiana University School of MedicineFellowship, Pediatric Hematology/Oncology, 1993 - 1996
University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 1990 - 1993
University of Minnesota Medical SchoolClass of 1990
Certifications & Licensure
IN State Medical License 1993 - 2025
Publications & Presentations
PubMed
- 10 citationsACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma.Isabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, Sabine Mueller, Burt Nabors
Neuro-Oncology. 2024-05-03 - 11 citationsONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, Dolly Aguilera, Joshua E Allen
Journal of Clinical Oncology. 2024-05-01 - 5 citationsExpanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.Patrick M. Forde, P. Bonomi, Alice T. Shaw, Gideon M. Blumenthal, Andrea Ferris
Clinical Lung Cancer. 2020-02-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
